Merck Pulls Victrelis in the U.S – Gilead and Abbvie still rule HEP C

By |2015-01-21T18:35:37+00:00January 21st, 2015|Uncategorized|

Vertex pulled Incivek, Merck pulls Victrelis, and what will J&J do with the other HEP C compound competing against Gilead and Abbvie? Merck has a few rabbits up their sleeve with a potential approval this year and some M&A, but for now, the battle continues. SMZ

Read More
Comments Off on Merck Pulls Victrelis in the U.S – Gilead and Abbvie still rule HEP C

Health Experts: Say No to Randomized Trials Testing Ebola Drugs

By |2017-04-25T18:03:53+00:00November 24th, 2014|Pharma News|

Karla Burke Life Sciences Senior Marketing Specialist at Thomson ReutersTop Contributor Leading health experts said that having decided it is ethical to use non-approved products to help deal with the Ebola virus epidemic, it would be unethical if those drugs were administered in the context of randomized clinical trials. “No one insisted Western medical workers [...]

Read More
Comments Off on Health Experts: Say No to Randomized Trials Testing Ebola Drugs
Go to Top